IntelGenx Technologies Corp.
IGX
株式のランク
#28125
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
株価
$0.17446996
最終同期: 2024-06-11
時価総額
$26.97M
変化（1日）
-0.57%
変化（1年）
2.63%
国
CA
取引 IntelGenx Technologies Corp. (IGX)
カテゴリー
Healthcare
IntelGenx Technologies Corp.（IGX）の発行済株式数
March 2024 時点の発行済株式数 174.66M
IntelGenx Technologies Corp. の最新の財務報告および株価によると、現在の発行済株式数は 174.66M です。December 2022 の終わりには、同社は 164.75M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
IntelGenx Technologies Corp.（IGX）の発行済株式数の履歴（2003 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 174.66M | 0.00% |
| 2023 | 174.65M | 6.01% |
| 2022 | 164.75M | 20.25% |
| 2021 | 137.00M | 26.34% |
| 2020 | 108.44M | 15.95% |
| 2019 | 93.53M | 26.18% |
| 2018 | 74.12M | 12.05% |
| 2017 | 66.15M | 3.43% |
| 2016 | 63.96M | 0.68% |
| 2015 | 63.52M | 0.54% |
| 2014 | 63.18M | 16.95% |
| 2013 | 54.02M | 8.84% |
| 2012 | 49.64M | 13.49% |
| 2011 | 43.74M | 23.81% |
| 2010 | 35.33M | 44.02% |
| 2009 | 24.53M | 24.78% |
| 2008 | 19.66M | 22.53% |
| 2007 | 16.04M | 11.91% |
| 2006 | 14.34M | 30.42% |
| 2005 | 10.99M | 632.73% |
| 2004 | 1.50M | 0.00% |
| 2003 | 1.50M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 253.90M | 45.37% |
US
|
|
| 396.00M | 126.73% |
US
|
|
| 478.91M | 174.20% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -64.40% |
NL
|
